Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
4.410
-0.120 (-2.65%)
Dec 26, 2025, 4:00 PM EST - Market closed

Sana Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
1,1753648047502,833-
Upgrade
Market Cap Growth
112.15%-54.75%7.21%-73.52%--
Upgrade
Enterprise Value
1,1112616333502,066-
Upgrade
Last Close Price
4.411.634.083.9515.48-
Upgrade
PB Ratio
5.921.452.801.503.89-
Upgrade
P/TBV Ratio
-7.189.172.515.36-
Upgrade
Debt / Equity Ratio
0.460.410.360.220.150.17
Upgrade
Quick Ratio
4.313.363.183.805.5512.03
Upgrade
Current Ratio
4.563.543.313.995.6212.22
Upgrade
Return on Equity (ROE)
-96.11%-99.17%-72.00%-43.90%-61.36%-80.76%
Upgrade
Return on Assets (ROA)
-23.90%-31.82%-29.44%-17.38%-21.85%-28.41%
Upgrade
Return on Capital (ROIC)
-35.30%-45.61%-40.90%-23.45%-30.25%-39.39%
Upgrade
Return on Capital Employed (ROCE)
-47.60%-59.60%-65.30%-38.20%-31.60%-37.30%
Upgrade
Earnings Yield
-19.96%-73.30%-35.22%-35.92%-12.56%-
Upgrade
FCF Yield
-13.52%-70.50%-34.02%-41.45%-9.91%-
Upgrade
Buyback Yield / Dilution
-10.01%-18.68%-3.29%-13.16%-1178.88%-165.43%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q